NCT00419484CompletedNot Applicable
Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Dokkyo Medical University
- Enrollment
- 1,000
- Locations
- 1
Study Overview
Brief Summary
We want to investigate the effects of pioglitazone on cardiovascular events in Japanese patients with type 2 diabetes.
Detailed Description
Primary composite endpoints:
Cardiovascular death Non-fatal myocardial infarction and angina Non-fatal stroke Renal failure (hemodialysis/doubling of serum creatinine)
Secondary endpoints:
urinary albumin excretion diabetic retinopathy hyperlipidemia hypertension gout
Study Design
- Study Type
- Observational
- Observational Model
- Defined Population
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 20 Years to 70 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •type 2 diabetes HbA1c: more than 7% and less than 9%
Exclusion Criteria
- •insulin treatment
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 4
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus ParticipantsType 2 Diabetes Mellitus in ObeseHeart Failure With Preserved Ejection FractionNCT05838287The University of Texas Health Science Center at San Antonio78
Completed
Phase 4
Effect of pioglitazone on cardiovascular events in high-risk diabetic patients with acute brain infarctioAcute brain infarction with type2 diabetes mellitus.JPRN-UMIN000001112Kyushu University600
Terminated
Phase 4
Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)Myocardial InfarctionDiabetes MellitusNCT00212004National Cerebral and Cardiovascular Center, Japan630
Completed
Phase 2
Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.Diabetes MellitusNCT00770640Takeda40
Completed
Phase 2
Effects of pioglitazone on coronary atherosclerotic plaques of patients with impaired glucose tolerance or type 2 diabetes mellitus:a randomized,open rabelled,prospective study.Impaired glucose tolerance or type 2 diabetes mellitus with coronary artery diseaseJPRN-C000000230Chiba University Graduate School of Medicine40